Industry News
Success Of 'Quadrapeutics' shown in preclinical study of hard-to-treat tumors
Jun 04, 2014
The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer... Read More
Hormone discovered that controls supply of iron in red blood cell production
Jun 04, 2014
A UCLA research team has discovered a new hormone called erythroferrone, which regulates the iron supply needed for red blood-cell production. Read More
Many breast cancer patients don't get treatment for heart problems
Jun 03, 2014
Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems, in a study presented at the American Heart Association's Quality of Care and Outcomes... Read More
Immunotherapy trials reveal 'encouraging' results for melanoma treatment
Jun 03, 2014
Two new studies reveal how the drugs nivolumab, ipilimumab and pembrolizumab improved overall survival for patients with advanced melanoma, showing promise for new treatments. Read More
Patients with terminal illnesses benefit from stopping statins
Jun 03, 2014
Cholesterol-lowering statins are widely used, but new research suggests patients in late stages of terminal illnesses may extend their lives by discontinuing use of the drug. Read More
VELCADE Phase 3 study results presented for patients with mantle cell lymphoma
Jun 03, 2014
Millennium: The Takeda Oncology Company has announced results from the primary analysis of an international, randomized Phase 3 study that showed treatment with a VELCADE® (bortezomib)-based... Read More
Reduced kidney function associated with higher risk of renal and urothelial cancer
Jun 03, 2014
A key measure of reduced kidney function and chronic kidney disease - reduced glomerular filtration rate - is an independent risk factor for renal and urothelial cancer, according to a study... Read More
New treatment option for young women with hormone-sensitive breast cancer
Jun 03, 2014
The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in young women who also receive ovarian function suppression as adjuvant (post-surgery)... Read More
Study finds risk of recurrence low in smallest HER2+ breast cancer tumors
Jun 03, 2014
Patients with specific HER2+ breast cancer tumors had a low risk of the cancer recurring five years after diagnosis, even without chemotherapy or treatment with a common antibody, according to a... Read More
Risk of secondary cancers increased following radiation for prostate cancer
Jun 03, 2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan... Read More
Previous Page Next Page